Rho kinase inhibitor enables cell-based therapy for corneal endothelial dysfunction

The corneal endothelium maintains corneal transparency; consequently, its dysfunction causes severe vision loss. Tissue engineering-based therapy, as an alternative to conventional donor corneal transplantation, is anticipated to provide a less invasive and more effective therapeutic modality. We co...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Sci Rep
Autors principals: Okumura, Naoki, Sakamoto, Yuji, Fujii, Keita, Kitano, Junji, Nakano, Shinichiro, Tsujimoto, Yuki, Nakamura, Shin-ichiro, Ueno, Morio, Hagiya, Michio, Hamuro, Junji, Matsuyama, Akifumi, Suzuki, Shingo, Shiina, Takashi, Kinoshita, Shigeru, Koizumi, Noriko
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 2016
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4870691/
https://ncbi.nlm.nih.gov/pubmed/27189516
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep26113
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars